📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Construction and validation of safe Clostridium botulinum Group II surrogate strain producing inactive botulinum neurotoxin type E toxoid. (2022)

First Author: Nowakowska MB

Attributed to: SBRC NOTTINGHAM: Sustainable Routes to Platform Chemicals funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41598-022-05008-1

PubMed Identifier: 35110559

Publication URI: http://europepmc.org/abstract/MED/35110559

Type: Journal Article/Review

Volume: 12

Parent Publication: Scientific reports

Issue: 1

ISSN: 2045-2322